Structured Discharge and Follow-up Protocol for COPD Patients Receiving LTOT and NIV
The Effectiveness of Structured Discharge and Follow-up Protocol on Readmission Rate in COPD Patients Receiving LTOT and NIV: A Multicenter Randomized Trial
Sponsor: Ataturk University
This NA trial investigates COPD Exacerbation and Chronic Respiratory Failure and is currently ongoing. Ataturk University leads this study, which shows 12 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Nov 2025 — Present [monthly]
Unknown NA
-
Sep 2025 — Nov 2025 [monthly]
Unknown NA
-
Jan 2025 — Sep 2025 [monthly]
Unknown NA
-
Sep 2024 — Jan 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
▶ Show 7 earlier versions
-
Feb 2023 — Jul 2024 [monthly]
Unknown Status NA
-
Oct 2021 — Feb 2023 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Active Not Recruiting NA
-
Aug 2019 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jul 2019 — Aug 2019 [monthly]
Recruiting NA
-
Jun 2018 — Jul 2019 [monthly]
Recruiting NA
-
May 2018 — Jun 2018 [monthly]
Recruiting NA
First recorded
Nov 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ataturk University
- Atatürk Chest Diseases and Chest Surgery Training and Research Hospital
- Celal Bayar University
- Cukurova University
- Diskapi Yildirim Beyazit Education and Research Hospital
- Dokuz Eylul University
- Duzce University
- Ege University
- Gazi University
- Hacettepe University
- Istanbul Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital
- Istanbul University - Cerrahpasa
- Ordu University
- Turkish Directorate General of Public Health
- Uludag University
For direct contact, visit the study record on ClinicalTrials.gov .